NO20081835L - Behandlingsmetoder ved bruk av oksytocin receptoragonister - Google Patents
Behandlingsmetoder ved bruk av oksytocin receptoragonisterInfo
- Publication number
- NO20081835L NO20081835L NO20081835A NO20081835A NO20081835L NO 20081835 L NO20081835 L NO 20081835L NO 20081835 A NO20081835 A NO 20081835A NO 20081835 A NO20081835 A NO 20081835A NO 20081835 L NO20081835 L NO 20081835L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- receptor agonists
- treatment
- oxytocin receptor
- schizophrenia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72965605P | 2005-10-24 | 2005-10-24 | |
PCT/US2006/040425 WO2007050353A2 (fr) | 2005-10-24 | 2006-10-17 | Methodes de traitement utilisant des agonistes du recepteur d'oxytocine |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081835L true NO20081835L (no) | 2008-05-20 |
Family
ID=37834124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081835A NO20081835L (no) | 2005-10-24 | 2008-04-16 | Behandlingsmetoder ved bruk av oksytocin receptoragonister |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070117794A1 (fr) |
EP (1) | EP1948662A2 (fr) |
JP (1) | JP2009512730A (fr) |
KR (1) | KR20080063848A (fr) |
CN (1) | CN101296929A (fr) |
AU (1) | AU2006306547A1 (fr) |
BR (1) | BRPI0617770A2 (fr) |
CA (1) | CA2626180A1 (fr) |
CR (1) | CR9923A (fr) |
EC (1) | ECSP088398A (fr) |
GT (1) | GT200800052A (fr) |
IL (1) | IL190900A0 (fr) |
NO (1) | NO20081835L (fr) |
RU (1) | RU2008114374A (fr) |
WO (1) | WO2007050353A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2954167A1 (fr) | 2009-09-04 | 2011-06-24 | Centre Nat Rech Scient | Traitement par l'ocytocine de caracteristiques comportementales associees a l'autisme et a la timidite pathologique |
CA2799733A1 (fr) | 2010-05-18 | 2011-11-24 | Universite De Geneve | Nouvelles utilisations de molecules de type oxytocine et procedes associes |
WO2011146806A1 (fr) * | 2010-05-21 | 2011-11-24 | University Of Florida Research Foundation, Inc. | Procédés de réduction des effets épiléptogènes et neurotoxiques inductibles par un anesthésique |
WO2012016229A2 (fr) | 2010-07-30 | 2012-02-02 | The Regents Of The University Of California | Traitement à l'ocytocine visant à améliorer la mémoire et abaisser le taux de glucose dans le sang |
WO2016025629A1 (fr) | 2014-08-12 | 2016-02-18 | The Regents Of The University Of California | Composition moléculaire permettant d'améliorer et de renouveler l'entretien et la réparation des tissus de mammifère |
EP3328864B1 (fr) | 2015-07-06 | 2022-09-07 | Kinoxis Therapeutics Pty Ltd | Composés et compositions thérapeutiques pour le traitement de troubles sociaux et de troubles liés à la toxicomanie |
KR102561721B1 (ko) * | 2016-12-12 | 2023-07-28 | 키녹시스 테라퓨틱스 피티와이 리미티드 | 비펩티드성 옥시토신 수용체 작용제 |
CN111867632A (zh) | 2018-03-23 | 2020-10-30 | 赛途公司 | 骨骼肌肥大诱导剂的alk5抑制剂 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6900200B2 (en) * | 2001-04-12 | 2005-05-31 | Wyeth | Tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
GB0115515D0 (en) * | 2001-06-25 | 2001-08-15 | Ferring Bv | Oxytocin agonisys |
GB0120051D0 (en) * | 2001-08-16 | 2001-10-10 | Ferring Bv | Oxytocin agonists |
EP1449844A1 (fr) * | 2003-02-14 | 2004-08-25 | Ferring B.V. | derives de benzamide agonistes de l'ocytocine et antagonistes de la vasopressine |
EP1512687A1 (fr) * | 2003-09-05 | 2005-03-09 | Ferring B.V. | Piperazines comme agonistes d'oxytocin |
-
2006
- 2006-10-17 EP EP06826053A patent/EP1948662A2/fr not_active Withdrawn
- 2006-10-17 CA CA002626180A patent/CA2626180A1/fr not_active Abandoned
- 2006-10-17 KR KR1020087012049A patent/KR20080063848A/ko not_active Application Discontinuation
- 2006-10-17 WO PCT/US2006/040425 patent/WO2007050353A2/fr active Application Filing
- 2006-10-17 BR BRPI0617770-0A patent/BRPI0617770A2/pt not_active Application Discontinuation
- 2006-10-17 AU AU2006306547A patent/AU2006306547A1/en not_active Abandoned
- 2006-10-17 CN CNA200680039564XA patent/CN101296929A/zh active Pending
- 2006-10-17 JP JP2008537762A patent/JP2009512730A/ja not_active Withdrawn
- 2006-10-17 RU RU2008114374/14A patent/RU2008114374A/ru unknown
- 2006-10-23 US US11/584,995 patent/US20070117794A1/en not_active Abandoned
-
2008
- 2008-04-15 IL IL190900A patent/IL190900A0/en unknown
- 2008-04-16 NO NO20081835A patent/NO20081835L/no not_active Application Discontinuation
- 2008-04-24 GT GT200800052A patent/GT200800052A/es unknown
- 2008-04-24 CR CR9923A patent/CR9923A/es not_active Application Discontinuation
- 2008-04-24 EC EC2008008398A patent/ECSP088398A/es unknown
Also Published As
Publication number | Publication date |
---|---|
WO2007050353A3 (fr) | 2007-06-21 |
EP1948662A2 (fr) | 2008-07-30 |
WO2007050353A2 (fr) | 2007-05-03 |
US20070117794A1 (en) | 2007-05-24 |
AU2006306547A1 (en) | 2007-05-03 |
CR9923A (es) | 2008-06-27 |
GT200800052A (es) | 2008-10-06 |
ECSP088398A (es) | 2008-06-30 |
JP2009512730A (ja) | 2009-03-26 |
IL190900A0 (en) | 2008-11-03 |
CN101296929A (zh) | 2008-10-29 |
CA2626180A1 (fr) | 2007-05-03 |
KR20080063848A (ko) | 2008-07-07 |
RU2008114374A (ru) | 2009-12-10 |
BRPI0617770A2 (pt) | 2011-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081835L (no) | Behandlingsmetoder ved bruk av oksytocin receptoragonister | |
UA109878C2 (uk) | Похідні ізохінолінону, фармацевтична композиція на їх основі (варіанти) та спосіб лікування захворювань (варіанти) | |
CY1121135T1 (el) | Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος | |
EA201000016A1 (ru) | Способы и композиции для лечения рака, опухолей и нарушений, связанных с опухолями | |
EA201000603A1 (ru) | ПРИМЕНЕНИЕ АНТИТЕЛ К TrkB ДЛЯ ЛЕЧЕНИЯ РЕСПИРАТОРНЫХ НАРУШЕНИЙ | |
DE602006008456D1 (de) | Amylin und amylinagonisten für die behandlung von psychiatrischen erkrankungen und störungen | |
EA200700262A1 (ru) | Арилидены для лечения заболеваний, опосредуемых эстроген-родственным рецепторам альфа | |
MX2010002732A (es) | Inhibidores de f1f0-atpasa y metodos relacionados. | |
ATE528002T1 (de) | Pyridoncarboxamidderivate zur behandlung hyperproliferativer und angiogenese-vermittelter leiden | |
BRPI0506970B8 (pt) | derivados de alfa-aminoamida úteis no tratamento de distúrbios do trato urinário inferior | |
EA201301078A1 (ru) | Новые терапевтические подходы в лечении смт и связанных с ней расстройств | |
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
ATE478072T1 (de) | Spiroimidazol-derivate als ppar-modulatoren | |
NO20074943L (no) | Roflumilast for behandlingen av diabetes mellitus | |
ATE497961T1 (de) | Als proteinkinaseinhibitoren geeignete verbindungen | |
SG179410A1 (en) | Therapeutic uses of inhibitors of rtp801 | |
ATE484501T1 (de) | Als protein-kinase-inhibitoren nutzbare benzimidazole | |
CL2008002162A1 (es) | Compuestos derivados de 3-benzoisoxazol-piperidin; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento y/o prevencion de trastornos cognitivos, adiccion a drogas, depresion, ansiedad, entre otras. | |
EA201070609A1 (ru) | Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств | |
NO20092634L (no) | Fremgangsmate for fremstilling av piperazinyl og diazepanyl benzamidderivater | |
UY29995A1 (es) | Uso de un antagonista de cb1 para tratar efectos secundarios y síntomas negativos de la esquizofrenia | |
NI200700032A (es) | Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas | |
EA200802072A1 (ru) | Ликопин для лечения нарушения обмена веществ | |
AR060786A1 (es) | Variaciones cristalinas de (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina | |
NO20091052L (no) | Diaryleterderivater og anvendelser derav |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |